Weight-loss surgeries for adolescents increased 15% in the U.S. between 2021 and 2023, even as the Food and Drug ...

As sure as the sun rises, prescription medicine use and total drug spending continues to increase in the U.S. | Last year's ...

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

Last year, more than 16 million people googled 'semaglutide' - sold under the brand names Wegovy and Ozempic - as demand for ...

Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent risk factor for falls in people with type 2 diabetes.

The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...

The early results for stop-loss claims, or claims for catastrophic losses, are in line with the insurer's expectations, ...

The use of GLP-1s among patients with type 2 diabetes appeared associated with significantly reduced risk for certain ...

Three Motley Fool contributors think they've found no-brainer healthcare stocks to buy in May. Here's why they picked Eli ...

On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...

Speaking at Berkshire's annual meeting in Omaha, Buffett Says Greg Abel Should Succeed at Year-End. Auto lenders tightened lending in recent years after the pandemic car-buying frenzy.

Decades of studies and statistics have shown that women are consistently held back in the workplace because of their gender.